Adjuvant administration modulates the process of beta‐cell autoimmunity and prevents IDDM: Introduction to human trials
- 1 December 1993
- journal article
- review article
- Published by Wiley in Diabetes/Metabolism Research and Reviews
- Vol. 9 (4) , 317-322
- https://doi.org/10.1002/dmr.5610090412
Abstract
No abstract availableThis publication has 47 references indexed in Scilit:
- Cellular and humoural autoimmunity markers in Type 2 (non-insulin-dependent) diabetic patients with secondary drug failureDiabetologia, 1992
- To Be Or Net To Be ASP 57, That Is The QuestionDiabetes Care, 1992
- Childhood Diabetes, Epidemics, and Epidemiology: An Approach for Controlling DiabetesAmerican Journal of Epidemiology, 1992
- Financing the Care of Diabetes Mellitus in the U.S.: Background, Problems, and ChallengesDiabetes Care, 1992
- Secular Trends in Incidence of Childhood IDDM in 10 CountriesDiabetes, 1990
- Rising Incidence of IDDM in EuropeDiabetes Care, 1989
- Increasing incidence of diabetes mellitus in Norwegian children 0?14 years of age 1973?1982Diabetologia, 1989
- Type I Diabetes MellitusNew England Journal of Medicine, 1986
- Islet Cell Antibodies Identify Latent Type I Diabetes in Patients Aged 35–75 Years at DiagnosisDiabetes, 1986
- Incidence of Insulin‐Dependent Diabetes Mellitus (0–29 Years at Onset) in DenmarkActa Medica Scandinavica, 1979